18 February 2025 in Plastic Surgery
Introduction: Self-examinations for skin cancer detection are limited by sensitivity. ChatGPT-4 has image recognition capabilities that can be a useful adjunct for screening cancers and tele-health applications. This study investigated the efficacy of ChatGPT-4 in identifying skin lesions. Methods: Dermoscopic images were retrospectively selected from the PH 2 dataset, categorized by clinical diagnosis, and uploaded to ChatGPT-4 with a predesigned prompt. Responses were compared against clinical diagnoses. Confidence intervals were calculated using the bootstrap method assessing precision and significance was calculated using McNemar's test. Analyses were performed using Jupyter Notebook and Python. Results: The GPT-4 model showed moderate performance in melanoma detection with 68.5% accuracy, 52.5% sensitivity, and 72.5% specificity, significantly differing from the clinical standard ( P = .002). For suspicious lesion detection, it performed better with 68.0% accuracy, 78.0% precision, and 70.0% F-measure, still not closely matching clinical diagnosis for atypical nevi and melanoma ( P = .0169). Conclusion: The statistical difference between ChatGPT-4 diagnosis of melanoma and suspicious lesions compared with clinical diagnoses and other AI models suggests the need for improvement in ChatGPT-4 algorithms. This study's limitations included the use of a secondary care database with a higher melanoma incidence, high-quality dermoscopic images that limit generalizability, a small sample size lacking diversity, and the need for larger datasets to validate findings in broader contexts.
14 June 2025 in Journal of Cutaneous Medicine and Surgery
12 November 2025 in Journal of Cutaneous Medicine and Surgery
Background: Hidradenitis suppurativa (HS) is a chronic, immune-mediated skin disorder affecting intertriginous areas, frequently leading to painful nodules, abscesses, sinus tracts, and scarring. In patients with moderate-to-severe disease (Hurley Stages II and III), surgical intervention is frequently required to achieve durable disease control. Objective: To compare and evaluate the surgical interventions employed in Hurley Stage II and III HS by evaluating recurrence rates, postoperative complications, and patient-centred outcomes across different operative modalities. Methods: A comprehensive search of MEDLINE and EMBASE identified studies reporting surgical outcomes in Hurley Stage II and III HS. English-language studies describing postoperative recurrence, complications, and patient-centred outcomes stratified by surgical intervention were included. Of 647 studies screened, 136 studies were included. Results: A total of 136 studies were included (5,646 procedures). Primary closure had the highest recurrence (38.0%) and complication rates (29.4%). Wide excision (n = 1923) showed moderate recurrence (17.2%) and the highest cosmetic dissatisfaction. Laser-assisted surgery had the lowest complication rate (2.2%) and recurrence rate (5.7%). Flaps and grafts showed higher complication rates but fewer recurrences than primary closure. Conclusion: Surgical outcomes in advanced HS vary by intervention. Primary closure is associated with the highest rates of recurrence and complications, while wide excision and laser-assisted surgery may offer improved disease control. These findings support individualized surgical planning in Stage II and III HS.
16 July 2026 in Clinical and Experimental Dermatology
Psoriasis is a chronic, immune-mediated inflammatory disease in which durable, treatment-free remission is rarely achieved despite highly effective biologic therapies. We report a 60-year-old woman with a 49-year history of severe plaque psoriasis who developed complete and sustained disease clearance following autologous CD19-directed chimeric antigen receptor T-cell (CAR-T) therapy for follicular lymphoma. Psoriasis resolved within 4 weeks of CD19 CAR-T therapy, and the patient has remained in remission for 5 years without any psoriasis-directed treatment. This observation, together with emerging reports, suggests that deep tissue depletion of B-lymphoid lineage cells in psoriasis may induce long-term disease modification. Mechanistically, CD19 CAR-T therapy targets a broader spectrum of B-cell populations than anti-CD20 approaches, potentially disrupting pathogenic B–T-cell interactions and autoreactive immune circuits. These findings challenge the prevailing T-cell-centric paradigm of psoriasis and support exploration of B-cell-directed, immune reset strategies as a route towards durable remission or cure.
30 September 2026 in Journal of Cutaneous Medicine and Surgery
15 January 2026 in Journal of Cutaneous Medicine and Surgery